Company news

Biodesix, Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Biodesix Announces Publication Highlighting Interim Data from the INSIGHT Study Assessing the Clinical Effectiveness of VeriStrat® Proteomic Test in the Journal of Immunotherapy of Cancer

November 17, 2021

Biodesix Announces Third Quarter 2021 Results and Highlights

November 14, 2021

Biodesix to Report Third Quarter 2021 Financial Results on November 15, 2021

October 31, 2021

Biodesix Announces New Data on Nodify Lung® Nodule Risk Assessment Testing at the CHEST 2021 Annual Meeting

October 12, 2021

Biodesix Announces Abstracts Presented During the IASLC 2021 World Conference on Lung Cancer

September 15, 2021

Biodesix DeSoto Laboratory Receives both ISO 13485: 2016 Certification and Accreditation from the College of American Pathologists

August 24, 2021

Biodesix Announces Second Quarter 2021 Results and Highlights

August 9, 2021

Biodesix to Report Second Quarter 2021 Financial Results on August 10, 2021

July 26, 2021

Biodesix Announces Commercial Availability of SARS CoV-2 Neutralization Antibody Test

June 14, 2021

Biodesix Partners with Datavant to Enhance Value of Lung Cancer Databank

June 3, 2021

Biodesix Announces First Quarter 2021 Results

May 10, 2021

Biodesix Announces Intent to Launch Liquid Biopsy Next Generation Sequencing Test with Unprecedented Turnaround Time

April 27, 2021

Biodesix to Report First Quarter 2021 Financial Results on May 11, 2021

April 25, 2021

Biodesix Announces Presentation on SARS-CoV-2 Neutralizing Antibody Testing for Individual Vaccine Response and Commercial Launch Plans

April 25, 2021

Biodesix Announces Presentation on Use of Biomarker-Based Risk Assessment to Inform Lung Nodule Management

April 21, 2021

Biodesix Releases New Data at AACR on Proteomic Profiling to Help Guide Physician Treatment Strategies for NSCLC Patients

April 9, 2021

Biodesix Announces Issuance of Two U.S. Patents, Expands Coverage of Diagnostic Methods to Improve Care for Cancer Patients

April 5, 2021

Biodesix Announces Closing of New $30 Million Term Loan

March 22, 2021

Biodesix Announces Fourth Quarter and Full Year 2020 Results

March 15, 2021

Biodesix to Report Fourth Quarter and Fiscal 2020 Financial Results on March 16, 2021

March 8, 2021

Biodesix Partners with Chicago Public Schools for COVID-19 Testing to Safely Reopen Schools

February 15, 2021

Biodesix Anticipates Strong Preliminary Fourth Quarter 2020 Revenue (unaudited)

January 7, 2021

Biodesix Announces Hiring of Ryan Siurek as Chief Accounting Officer

January 4, 2021

Biodesix Initiates Biomarker Study to Affirm Nodify XL2® Test’s Importance in Clinical Decision Making

December 22, 2020

Biodesix Announces Third Quarter 2020 Results and Provides Corporate Update

December 9, 2020

Biodesix Announces Closing of Initial Public Offering

October 29, 2020

Biodesix Announces Pricing of Initial Public Offering

October 27, 2020

← Newer news releases

Calls

The 5 newest of 23 calls. Every call is listed under its year.

Decks